Ocular adverse events associated with platins: a disproportionality analysis of pharmacovigilance data and extensive systematic review of case reports

The study revealed a potential risk of OAEs when using platinum-based chemotherapy drugs as an anticancer medication.

Authors

Institutions

Publication Details

Journal
Expert Opinion on Drug Safety
Published
2024-08-13
DOI
https://doi.org/10.1080/14740338.2024.2392860
Citations
3
Primary Topic
Drug-Induced Ocular Toxicity
Type
article
Field-Weighted Citation Impact
1.62
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ocular adverse events associated with platins: a disproportionality analysis of pharmacovigilance data and extensive systematic review of case reports

Krishna Undela, Christy Thomas, P. N. Hasik, Munlima Hazarika
3 citations
Expert Opinion on Drug Safety
Drug-Induced Ocular Toxicity
1.62
article

Ocular adverse events associated with platins: a disproportionality analysis of pharmacovigilance data and extensive systematic review of case reports

Krishna Undela, Christy Thomas, P. N. Hasik, Munlima Hazarika
article en
3 citations

Abstract

The study revealed a potential risk of OAEs when using platinum-based chemotherapy drugs as an anticancer medication.

Expert Opinion on Drug SafetyVol. 24(10)
Bhubaneswar Borooah Cancer Institute (IN), National Institute of Pharmaceutical Education and Research (IN)
Openalex Percentile: Top 17%
Drug-Induced Ocular Toxicity
1.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.